| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA3378561 | F | Agonist activity at muscarinic M1 receptor (unknown origin) at 0.3 uM by calcium mobilization assay | Homo sapiens | 4 | ALA3351422 | assay format | Scientific Literature | |
| 2. | ALA3378563 | F | Agonist activity at muscarinic M2 receptor (unknown origin) at 0.3 uM by calcium mobilization assay | Homo sapiens | 4 | ALA3351422 | assay format | Scientific Literature | |
| 3. | ALA3380405 | F | Agonist activity at muscarinic M3 receptor (unknown origin) at 0.3 uM by calcium mobilization assay | Homo sapiens | 4 | ALA3351422 | assay format | Scientific Literature | |
| 4. | ALA3380407 | F | Agonist activity at muscarinic M4 receptor (unknown origin) at 0.3 uM by calcium mobilization assay | Homo sapiens | 6 | ALA3351422 | assay format | Scientific Literature | |
| 5. | ALA3380408 | F | Agonist activity at muscarinic M5 receptor (unknown origin) at 10 uM by calcium mobilization assay | Homo sapiens | 11 | ALA3351422 | assay format | Scientific Literature | |
| 6. | ALA3380409 | B | Inhibition of human ERG channel | Homo sapiens | 11 | ALA3351422 | single protein format | Scientific Literature | |
| 7. | ALA3380410 | P | Lipophilicity, log P of the compound | 3 | ALA3351422 | small-molecule physicochemical format | Scientific Literature | ||
| 8. | ALA3380411 | A | Oral bioavailability in rat at 2.5 mg/kg | Rattus norvegicus | 2 | ALA3351422 | organism-based format | Scientific Literature | |
| 9. | ALA3380412 | A | Clearance in rat at 0.25 mg/kg, iv and 2.5 mg/kg, po | Rattus norvegicus | 4 | ALA3351422 | organism-based format | Scientific Literature | |
| 10. | ALA3380413 | A | Cmax in rat at 0.25 mg/kg, iv and 2.5 mg/kg, po | Rattus norvegicus | 1 | ALA3351422 | organism-based format | Scientific Literature | |
| 11. | ALA3380414 | A | Half life in rat at 0.25 mg/kg, iv and 2.5 mg/kg, po | Rattus norvegicus | 1 | ALA3351422 | organism-based format | Scientific Literature | |
| 12. | ALA3380415 | A | Volume of distribution at steady state in rat at 0.25 mg/kg, iv and 2.5 mg/kg, po | Rattus norvegicus | 1 | ALA3351422 | organism-based format | Scientific Literature | |
| 13. | ALA3371304 | A | Blood brain barrier penetration in rat at 0.25 mg/kg, iv and 2.5 mg/kg, po | Rattus norvegicus | 1 | ALA3351422 | organism-based format | Scientific Literature | |
| 14. | ALA3371305 | A | Oral bioavailability in dog at 1 mg/kg | Canis lupus familiaris | 1 | ALA3351422 | organism-based format | Scientific Literature | |
| 15. | ALA3371306 | A | Oral bioavailability in monkey at 2.5 mg/kg | Macaca mulatta | 1 | ALA3351422 | organism-based format | Scientific Literature | |
| 16. | ALA3371307 | A | Clearance in monkey at 0.25 mg/kg, iv and 2.5 mg/kg, po | Macaca mulatta | 1 | ALA3351422 | organism-based format | Scientific Literature | |
| 17. | ALA3371308 | A | Cmax in monkey at 0.25 mg/kg, iv and 2.5 mg/kg, po | Macaca mulatta | 1 | ALA3351422 | organism-based format | Scientific Literature | |
| 18. | ALA3371309 | A | Half life in monkey at 0.25 mg/kg, iv and 2.5 mg/kg, po | Macaca mulatta | 1 | ALA3351422 | organism-based format | Scientific Literature | |
| 19. | ALA3371310 | A | Volume of distribution at steady state in monkey at 0.25 mg/kg, iv and 2.5 mg/kg, po | Macaca mulatta | 1 | ALA3351422 | organism-based format | Scientific Literature | |
| 20. | ALA3371311 | F | Intrinsic activity at muscarinic M1 receptor (unknown origin) by calcium mobilization assay | Homo sapiens | 1 | ALA3351422 | assay format | Scientific Literature |
The page will load shortly, Thanks for your patience!